WSJ
Search documents
With Jobs Data Delayed, Analysts Flock to Unofficial Data
WSJ· 2026-02-04 10:30
Core Viewpoint - Numerous private firms provide insights into the job market, consumer behavior, and the economy, but these cannot substitute for official government statistics [1] Group 1 - Private firms offer various metrics and analyses related to employment and economic conditions [1] - The reliance on private data sources highlights the limitations of government statistics in capturing real-time economic trends [1] - Official government statistics remain essential for a comprehensive understanding of the economy [1]
Global Markets, U.S. Futures Steady After Heavy AI-Induced Selling
WSJ· 2026-02-04 09:45
Core Viewpoint - U.S. stock futures remained stable early Wednesday despite concerns regarding artificial intelligence threats impacting major software companies, which had previously caused declines in major indexes [1] Group 1 - Fears surrounding artificial intelligence have negatively affected major software companies, leading to a downturn in major stock indexes [1] - The stability in U.S. stock futures indicates a potential recovery or stabilization in the market following the recent declines [1]
Stock Market Today: Software Jitters Rattle Global Markets
WSJ· 2026-02-04 09:17
Dow futures edge up after Tuesday's selloff ...
Volvo Car Sales Fell in Three Months to End of January
WSJ· 2026-02-04 08:53
Group 1 - Global sales for the Swedish automaker decreased by 7.2% year-on-year [1] - The company now reports sales figures on a rolling three-month basis [1]
Henkel to Buy Coatings Company Stahl in $2.5 Billion Deal
WSJ· 2026-02-04 08:51
Group 1 - The consumer-goods company is expanding its adhesives arm through an acquisition [1]
Wegovy Maker Novo Nordisk's Shares Slump After Guidance Disappoints
WSJ· 2026-02-04 08:47
Group 1 - The stock experienced a significant decline of 19% at the opening bell in Copenhagen [1] - The company's outlook for the upcoming year did not meet investor expectations, leading to the stock drop [1]
Rolex Seller Watches of Switzerland Lifts Sales View on Strong Demand
WSJ· 2026-02-04 08:35
Core Insights - The U.K.-based group reported that demand for its core luxury brands remains strong and continues to outstrip supply in both its home market and the U.S. [1]
Carlsberg Net Profit Falls as Beer Consumption Declines
WSJ· 2026-02-04 07:56
Core Viewpoint - The Danish brewer is experiencing a decline in earnings as it increasingly shifts its focus towards soft drink offerings due to a decrease in consumer demand for beer [1] Group 1: Earnings Performance - Earnings have fallen for the company, indicating a challenging financial environment [1] - The reliance on soft drink products is growing as a response to the softening consumer appetite for beer [1] Group 2: Market Trends - There is a noticeable shift in consumer preferences, with a decline in beer consumption impacting the company's traditional revenue streams [1] - The company is adapting its strategy to focus more on non-alcoholic beverages in light of changing market dynamics [1]
Zurich Insurance Reaches $11 Billion Deal to Buy U.K. Insurer Beazley
WSJ· 2026-02-04 07:54
Core Viewpoint - The Swiss insurer has been pursuing Beazley since last year, with several offers made public in January that were subsequently rejected [1] Group 1 - The Swiss insurer has shown interest in Beazley for an extended period, indicating a strategic move in the insurance sector [1] - Multiple offers were made by the Swiss insurer in January, highlighting the seriousness of their intentions [1] - Beazley has turned down these offers, suggesting a strong position or strategy on their part [1]
GSK's Specialty Medicines Drive Solid Results
WSJ· 2026-02-04 07:45
Core Insights - The pharma company achieved double-digit percentage growth in its immunology and inflammation, oncology, and HIV portfolios for 2025, with total sales reaching £32.67 billion [1] Group 1 - The company reported significant growth in its immunology and inflammation portfolio [1] - The oncology portfolio also experienced double-digit percentage growth [1] - The HIV portfolio contributed to the overall sales increase, reflecting strong performance [1]